Aerie pharmaceuticals to participate in the h.c. wainwright ophthalmology conference

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that casey c. kopczynski, ph.d., chief scientific officer, will participate in a virtual panel discussion titled, “what are the greatest unmet needs facing ophthalmology today?”, at
AERI Ratings Summary
AERI Quant Ranking